Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Securus Medical Group
company
About
Securus Medical Group develops clinical tools for monitoring core body temperature within body cavities.
Highlights
Details
- Last Funding Type
- Series C
- Last Funding Money Raised
- $10M
- Industries
- Biotechnology,Life Science
- Founded date
- Jan 1, 2011
- Operating Status
- Active
Securus Medical Group engages in the development of clinical tools to improve the safety and efficacy of ablation therapy by providing real-time, non-contact, high-resolution tissue temperature monitoring, and mapping products. The company engages in developing real-time, noncontact, thermal mapping systems to determine intrabody tissue temperatures.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$10M
Securus Medical Group has raised a total of
$10M
in funding over 2 rounds. Their latest funding was raised on
Sep 15, 2016 from a Series C round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Sep 15, 2016 | Series C | $10M | 2 |
Boston Scientific
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
2
Securus Medical Group is funded by 2 investors.
Boston Scientific
and Global Cardiovascular Innovation Center
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Boston Scientific
|
Yes | Series C |
Global Cardiovascular Innovation Center
|
— | Series C |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
